Diagnostic yield of endoscopic ultrasonography (EUS), EUS-guided fine-needle aspiration (EUS-FNA), cyst fluid tumour markers & cytology in pancreatic cystic neoplasms

Endoscopy ◽  
2006 ◽  
Vol 39 (S 1) ◽  
Author(s):  
R Repak ◽  
S Rejchrt ◽  
J Bartova ◽  
E Malirova ◽  
V Tycova ◽  
...  
2019 ◽  
Vol 92 (1) ◽  
pp. 15-20 ◽  
Author(s):  
Vlad Andrei Ichim ◽  
Romeo Ioan Chira ◽  
Petru Adrian Mircea

Endoscopic ultrasonography (EUS) has become an indispensable method for diagnosis and therapeutic procedures in gastroenterology. As experience with this technique grows, new indications continue to emerge. Due to the vicinity of the transducer to the liver, endoscopic ultrasonography provides detailed images of the liver segments and its vascular and biliary structures. Endosonographers have made an effort to define a clinical role for endoscopic ultrasound in liver diseases; however, not much is known about endoscopic ultrasound guided fine needle aspiration (EUS-FNA) in hepatic focal lesions. This review summarizes the available evidence regarding the usefulness of endoscopic ultrasound-guided fine needle aspiration in patients with focal liver lesions.  


2020 ◽  
Vol I (1) ◽  
pp. 11-16
Author(s):  
Shruti Mony

Background Endoscopic Ultrasonography-guided Fine Needle Aspiration (EUS-FNA), which is the preferred method for sampling gastrointestinal malignancies, is dependent on multiple factors. We aimed to evaluate if the experience of the on-site pathologist had an effect on the sample adequacy and tissue yield. Methods A single center, retrospective cohort study was conducted among patients undergoing EUS-FNA between 2015 to 2018 for solid GI lesions. Sample adequacy, pathologist experience, needle passes, size and cytological diagnosis was collected. On-site pathologist reported the sample adequacy. Results A total of 163 patients (47.2% male), median age 68 years, with solid GI lesions (79.8% pancreatic masses), were included. There was no significant correlation between the experience of pathologists and the number of EUS-FNA passes required to attain sample adequacy(r =0.158, p= 0.078). The mean number of passes to attain adequacy was not statistically significant between pathologists with <=10 years of experience versus those with >10 years of experience (1.94 vs. 1.97 passes). However, more experienced pathologists requested a greater number of EUS-FNA passes for an adequate sample compared to less experienced pathologists (4.05 vs. 3.23; p=0.003). Conclusions While there was no difference in determining sample adequacy based on pathologist experience, the experienced pathologists actually requested more FNA passes than less experienced ones. One rationale is that younger graduates have better exposure to EUS-FNA, leading to a greater level of confidence with securing a diagnosis. Further data is required to evaluate this effect. Keywords: Endoscopic Ultrasound; Pathologist Experience; Fine Needle Aspiration; Sample Adequacy; Diagnostic Yield.


Diagnostics ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. 954
Author(s):  
Kensaku Noguchi ◽  
Yousuke Nakai ◽  
Suguru Mizuno ◽  
Kenji Hirano ◽  
Sachiko Kanai ◽  
...  

Type 1 autoimmune pancreatitis (AIP) is histologically characterized by lymphoplasmacytic sclerosing pancreatitis (LPSP). Recently, the diagnostic yield of endoscopic ultrasonography-guided fine needle aspiration/biopsy (EUS-FNA/B) for AIP has been reported. However, its role in the diagnostic flow of AIP is not fully elucidated. We retrospectively reviewed 53 consecutive patients who were suspected with AIP and underwent EUS-FNA/B. We evaluated the contribution of EUS-FNA/B to the diagnosis of AIP before considering response to steroid therapy among patients with diffuse enlargement of the pancreas and those with focal enlargement, respectively. Twenty-two patients showed diffuse pancreatic enlargement and 31 showed focal enlargement. The final diagnosis was definitive AIP in 32 patients, probable AIP in 2, possible AIP in 1, and mass-forming focal pancreatitis in 18. There was no change in diagnosis after EUS-FNA/B among patients with diffuse pancreatic enlargement, while diagnosis changed in 38.7% (12/31) among those with focal enlargement—there was a probable to definitive diagnosis in 4 patients, unspecified to definitive in 3, and unspecified to probable in 5. EUS-FNB provided a significantly higher sensitivity for typical pathological findings of LPSP than EUS-FNA, and 10 patients were diagnosed as pathologically definitive AIP by EUS-FNB, though none were by EUS-FNA (p = 0.002). EUS-FNA/B was useful in the diagnosis of focal type AIP, and steroid therapy could be introduced after the diagnosis was confirmed. Meanwhile, EUS-FNA/B provided no contribution to diagnosis of diffuse type AIP. EUS-FNB showed a higher diagnostic yield than FNA.


2007 ◽  
Vol 51 (6) ◽  
pp. 925-933 ◽  
Author(s):  
Nicolas Roustan Delatour ◽  
Maria Luisa C. Policarpio-Nicolas ◽  
Hossein Yazdi ◽  
Shahidul Islam

Pancreatology ◽  
2013 ◽  
Vol 13 (1) ◽  
pp. 48-57 ◽  
Author(s):  
G.D. Thornton ◽  
M.J.W. McPhail ◽  
S. Nayagam ◽  
M.J. Hewitt ◽  
P. Vlavianos ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document